Changes in migraine treatment: how new classes of drugs can offer options for patients & prescribers

In this learning episode, we look at the latest developments in migraine treatment where new classes of drugs are starting to provide additional options for patients and prescribers. For links to relevant articles and further resources on migraine treatment visit the PJ website. Many thanks to Kerri Spalding, a migraine patient, advocate and fundraiser, and Mathew Garrod, lead pharmacist for neurosciences and specialist pharmacist at University Hospital Southampton NHS Foundation Trust, for their expertise and insights. This programme is presented by Alex Clabburn, senior editor — research and learning and was produced by Geoff Marsh.